Filed: 8/12/2026ACC: 0001819257-26-000005
📋 What this filing means
PATIENT SQUARE CAPITAL LP filed this quarterly 13F‑HR report disclosing 23 equity positions with a total reported market value of $645.52M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
23
Positions
$645.52M
Total AUM (reported)
22M
Total Shares
Allocation by class
SHS$283.86M44.0%
COM$213.17M33.0%
SPONSORED ADS$97.53M15.1%
SPONSORED ADR$21.34M3.3%
COM NEW$14.67M2.3%
COM STK$7.51M1.2%
ADS$7.44M1.2%
Portfolio Concentration
Top 3$366.05M56.7%
4–10$151.22M23.4%
11–25$128.26M19.9%
Top 3 weight
56.7%
Top 10 weight
80.1%
Voting Authority Distribution
Total shares with voting rights: 22M
Sole
Full voting authority
22M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole23
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings23
Rows:
ROIVANT SCIENCES LTD
SOLEShares8.02M
TypeSH
Market value$283.86M
43.97%
Sole
8.02M
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares276K
TypeSH
Market value$51.69M
8.01%
Sole
276K
Shared
0.00
None
0.00
MIRUM PHARMACEUTICALS INC
SOLEShares260.50K
TypeSH
Market value$30.50M
4.72%
Sole
260.50K
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares206.50K
TypeSH
Market value$27.52M
4.26%
Sole
206.50K
Shared
0.00
None
0.00
BEONE MEDICINES LTD
SOLEShares90.02K
TypeSH
Market value$25.65M
3.97%
Sole
90.02K
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares671.21K
TypeSH
Market value$23.21M
3.60%
Sole
671.21K
Shared
0.00
None
0.00
ARGENX SE
SOLEShares23K
TypeSH
Market value$21.34M
3.31%
Sole
23K
Shared
0.00
None
0.00
UNITED THERAPEUTICS CORP DEL
SOLEShares37.12K
TypeSH
Market value$20.11M
3.12%
Sole
37.12K
Shared
0.00
None
0.00
BELITE BIO INC
SOLEShares110K
TypeSH
Market value$16.94M
2.62%
Sole
110K
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares425K
TypeSH
Market value$16.45M
2.55%
Sole
425K
Shared
0.00
None
0.00
DBV TECHNOLOGIES S A
SOLEShares909.47K
TypeSH
Market value$14.92M
2.31%
Sole
909.47K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares220K
TypeSH
Market value$13.28M
2.06%
Sole
220K
Shared
0.00
None
0.00
BIONTECH SE
SOLEShares134.43K
TypeSH
Market value$12.51M
1.94%
Sole
134.43K
Shared
0.00
None
0.00
ARCUS BIOSCIENCES INC
SOLEShares355.80K
TypeSH
Market value$10.97M
1.70%
Sole
355.80K
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares212.50K
TypeSH
Market value$10.78M
1.67%
Sole
212.50K
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares108K
TypeSH
Market value$10.53M
1.63%
Sole
108K
Shared
0.00
None
0.00
ALLOGENE THERAPEUTICS INC
SOLEShares5.05M
TypeSH
Market value$10.50M
1.63%
Sole
5.05M
Shared
0.00
None
0.00
EYEPOINT INC
SOLEShares720K
TypeSH
Market value$10.30M
1.59%
Sole
720K
Shared
0.00
None
0.00
ARCUTIS BIOTHERAPEUTICS INC
SOLEShares370K
TypeSH
Market value$9.70M
1.50%
Sole
370K
Shared
0.00
None
0.00
C4 THERAPEUTICS INC
SOLEShares1.61M
TypeSH
Market value$7.51M
1.16%
Sole
1.61M
Shared
0.00
None
0.00
INVENTIVA SA
SOLEShares1.97M
TypeSH
Market value$7.44M
1.15%
Sole
1.97M
Shared
0.00
None
0.00
KYMERA THERAPEUTICS INC
SOLEShares47.50K
TypeSH
Market value$5.45M
0.84%
Sole
47.50K
Shared
0.00
None
0.00
FAETH THERAPEUTICS INC
SOLEShares175.05K
TypeSH
Market value$4.38M
0.68%
Sole
175.05K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ROIVANT SCIENCES LTDSOLE | SHS | 8.02M | SH | $283.86M 43.97% | 8.02M | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 276K | SH | $51.69M 8.01% | 276K | 0.00 | 0.00 |
MIRUM PHARMACEUTICALS INCSOLE | COM | 260.50K | SH | $30.50M 4.72% | 260.50K | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 206.50K | SH | $27.52M 4.26% | 206.50K | 0.00 | 0.00 |
BEONE MEDICINES LTDSOLE | SPONSORED ADS | 90.02K | SH | $25.65M 3.97% | 90.02K | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 671.21K | SH | $23.21M 3.60% | 671.21K | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 23K | SH | $21.34M 3.31% | 23K | 0.00 | 0.00 |
UNITED THERAPEUTICS CORP DELSOLE | COM | 37.12K | SH | $20.11M 3.12% | 37.12K | 0.00 | 0.00 |
BELITE BIO INCSOLE | SPONSORED ADS | 110K | SH | $16.94M 2.62% | 110K | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 425K | SH | $16.45M 2.55% | 425K | 0.00 | 0.00 |
DBV TECHNOLOGIES S ASOLE | SPONSORED ADS | 909.47K | SH | $14.92M 2.31% | 909.47K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 220K | SH | $13.28M 2.06% | 220K | 0.00 | 0.00 |
BIONTECH SESOLE | SPONSORED ADS | 134.43K | SH | $12.51M 1.94% | 134.43K | 0.00 | 0.00 |
ARCUS BIOSCIENCES INCSOLE | COM | 355.80K | SH | $10.97M 1.70% | 355.80K | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 212.50K | SH | $10.78M 1.67% | 212.50K | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 108K | SH | $10.53M 1.63% | 108K | 0.00 | 0.00 |
ALLOGENE THERAPEUTICS INCSOLE | COM | 5.05M | SH | $10.50M 1.63% | 5.05M | 0.00 | 0.00 |
EYEPOINT INCSOLE | COM NEW | 720K | SH | $10.30M 1.59% | 720K | 0.00 | 0.00 |
ARCUTIS BIOTHERAPEUTICS INCSOLE | COM | 370K | SH | $9.70M 1.50% | 370K | 0.00 | 0.00 |
C4 THERAPEUTICS INCSOLE | COM STK | 1.61M | SH | $7.51M 1.16% | 1.61M | 0.00 | 0.00 |
INVENTIVA SASOLE | ADS | 1.97M | SH | $7.44M 1.15% | 1.97M | 0.00 | 0.00 |
KYMERA THERAPEUTICS INCSOLE | COM | 47.50K | SH | $5.45M 0.84% | 47.50K | 0.00 | 0.00 |
FAETH THERAPEUTICS INCSOLE | COM NEW | 175.05K | SH | $4.38M 0.68% | 175.05K | 0.00 | 0.00 |